Home Tags Anti-BCMA

Tag: anti-BCMA

U.S. FDA Approves Belantamab Mafodotin as a Monotherapy in R/R Multiple...

The U.S. Food and Drug Administration has approved* belantamab mafodotin-blmf (Blenrep®; GlaxoSmithKline/GSK) as a monotherapy treatment for adult patients with relapsed or refractory multiple...

X